About this Journal Submit a Manuscript Table of Contents

Citations to this Journal [1,638 citations: 1–100 of 1,440 articles]

Articles published in Parkinson’s Disease have been cited 1,638 times. The following is a list of the 1,440 articles that have cited the articles published in Parkinson’s Disease.

  • Sinziana Mazilu, Ulf Blanke, Moran Dorfman, Eran Gazit, Anat Mirelman, Jeffrey M. Hausdorff, and Gerhard Tröster, “A Wearable Assistant for Gait Training for Parkinson’s Disease with Freezing of Gait in Out-of-the-Lab Environments,” ACM Transactions on Interactive Intelligent Systems, vol. 5, no. 1, pp. 1–31, 2015. View at Publisher · View at Google Scholar
  • Parneet Kaur, Arunachalam Muthuraman, and Manjinder Kaur, “The Implications of Angiotensin-Converting Enzyme and Their Modulators in Neurodegenerative Disorders: Current and Future Perspectives,” ACS Chemical Neuroscience, pp. 150213083557003, 2015. View at Publisher · View at Google Scholar
  • S. -M. Fereshtehnejad, M. Shafieesabet, G. A. Shahidi, A. Delbari, and J. Lokk, “Restless legs syndrome in patients with Parkinson's disease: a comparative study on prevalence, clinical characteristics, quality of life and nutritio,” Acta Neurologica Scandinavica, vol. 131, no. 4, pp. 211–218, 2015. View at Publisher · View at Google Scholar
  • S. Mazzucchi, D. Frosini, A. Ripoli, V. Nicoletti, G. Linsalata, U. Bonuccelli, and R. Ceravolo, “Serotonergic antidepressant drugs and L-dopa-induced dyskinesias in Parkinson's disease,” Acta Neurologica Scandinavica, vol. 131, no. 3, pp. 191–195, 2015. View at Publisher · View at Google Scholar
  • K. Knudsen, M. Flensborg Damholdt, K. Mouridsen, and P. Borghammer, “Olfactory function in Parkinson's Disease - effects of training,” Acta Neurologica Scandinavica, 2015. View at Publisher · View at Google Scholar
  • Monica Yadav, Nayeem U. Zia, and Shefali Walia, “Effect of Motor Versus Cognitive Secondary Tasks on Performance of Stair Descent in Community-Dwelling Older Adults,” Activities, Adaptation & Aging, vol. 39, no. 1, pp. 43–55, 2015. View at Publisher · View at Google Scholar
  • Ian James Martins, “LPS Regulates Apolipoprotein E and A<i>β</i> Interactionswith Effects on Acute Phase Proteins and Amyloidosis,” Advances in Aging Research, vol. 04, no. 02, pp. 69–77, 2015. View at Publisher · View at Google Scholar
  • Adrianna Carey, Rebecca Julian, Katlyn Kristeller, Peter Leonard, Sara Palmer, and Laura Krisa, “The Cardiovascular and Cerebrovascular Effects on Cognition in Persons with Parkinson’s Disease: A Systematic Review of the Literature,” Advances in Parkinson's Disease, vol. 04, no. 02, pp. 28–42, 2015. View at Publisher · View at Google Scholar
  • Rıfat Emrah Özel, Akhtar Hayat, and Silvana Andreescu, “Recent Developments in Electrochemical Sensors for the Detection of Neurotransmitters for Applications in Biomedicine,” Analytical Letters, vol. 48, no. 7, pp. 1044–1069, 2015. View at Publisher · View at Google Scholar
  • Matthew A. Schrager, James Hilton, Richard Gould, and Valerie E. Kelly, “Effects of blueberry supplementation on measures of functional mobility in older adults,” Applied Physiology, Nutrition, and Metabolism, pp. 1–7, 2015. View at Publisher · View at Google Scholar
  • Tomáš Krůček, Michala Korandová, Michal Šerý, Radmila Čapková Frydrychová, Tomáš Krůček, Michala Korandová, and Klára Szakosová, “ EFFECT OF LOW DOSES OF HERBICIDE PARAQUAT ON ANTIOXIDANT DEFENSE IN Drosophila ,” Archives of Insect Biochemistry and Physiology, 2015. View at Publisher · View at Google Scholar
  • Joanne Shanahan, Meg E. Morris, Orfhlaith Ni Bhriain, Jean Saunders, and Amanda M. Clifford, “Dance for People With Parkinson Disease: What Is the Evidence Telling Us?,” Archives Of Physical Medicine And Rehabilitation, vol. 96, no. 1, pp. 141–153, 2015. View at Publisher · View at Google Scholar
  • Christian Schlenstedt, Stephanie Brombacher, Gesa Hartwigsen, Burkhard Weisser, Bettina Moeller, and Guenther Deuschl, “Comparing the Fullerton Advanced Balance Scale With the Mini-BESTest and Berg Balance Scale to Assess Postural Control in Patients With Parkinson Dise,” Archives Of Physical Medicine And Rehabilitation, vol. 96, no. 2, pp. 218–225, 2015. View at Publisher · View at Google Scholar
  • Federico E. Micheli, Juan C. Giugni, Micke E. De Arco Espinosa, Daniela S. Calvo, and Gabriela B. Raina, “Piribedil and Pathological Gambling in six Parkinsonian patients,” Arquivos De Neuro-Psiquiatria, vol. 73, no. 2, pp. 115–118, 2015. View at Publisher · View at Google Scholar
  • Dana L. Dailey, Valerie J. Keffala, and Kathleen A. Sluka, “Do Cognitive and Physical Fatigue Tasks Enhance Pain, Cognitive Fatigue, and Physical Fatigue in People With Fibromyalgia?,” Arthritis Care & Research, vol. 67, no. 2, pp. 288–296, 2015. View at Publisher · View at Google Scholar
  • Aaron Kucinski, Roger L. Albin, Cindy Lustig, and Martin Sarter, “Modeling falls in Parkinson's disease: slow gait, freezing episodes and falls in rats with extensive striatal dopamine loss,” Behavioural Brain Research, 2015. View at Publisher · View at Google Scholar
  • Tivadar Lucza, Kázmér Karádi, János Kállai, Rita Weintraut, József Janszky, Attila Makkos, Sámuel Komoly, and Norbert Kovács, “Screening Mild and Major Neurocognitive Disorders in Parkinson’s Disease,” Behavioural Neurology, vol. 2015, pp. 1–10, 2015. View at Publisher · View at Google Scholar
  • Yongle Li, Jun Zhang, and Chunxiang Yang, “UNC-51-like kinase 1 blocks S6k1 phosphorylation contributes to neurodegeneration in Parkinson’s disease model in vitro,” Biochemical and Biophysical Research Communications, 2015. View at Publisher · View at Google Scholar
  • Jan Hejda, Ondrej Cakrt, Vladimir Socha, Jakub Schlenker, and Patrik Kutilek, “3-D trajectory of body sway angles: A technique for quantifying postural stability,” Biocybernetics and Biomedical Engineering, 2015. View at Publisher · View at Google Scholar
  • H. Zetterberg, G. E. Frykberg, J. Gäverth, and P. G. Lindberg, “Neural and Nonneural Contributions to Wrist Rigidity in Parkinson’s Disease: An Explorative Study Using the NeuroFlexor,” BioMed Research International, vol. 2015, pp. 1–8, 2015. View at Publisher · View at Google Scholar
  • Steno Rinalduzzi, Carlo Trompetto, Lucio Marinelli, Alessia Alibardi, Paolo Missori, Francesco Fattapposta, Francesco Pierelli, and Antonio Currà, “Balance Dysfunction in Parkinson’s Disease,” BioMed Research International, vol. 2015, pp. 1–10, 2015. View at Publisher · View at Google Scholar
  • Douglas A. Wajda, and Jacob J. Sosnoff, “Cognitive-Motor Interference in Multiple Sclerosis: A Systematic Review of Evidence, Correlates, and Consequences,” BioMed Research International, vol. 2015, pp. 1–8, 2015. View at Publisher · View at Google Scholar
  • Sabine Skodda, “Steadiness of syllable repetition in early motor stages of Parkinson's disease,” Biomedical Signal Processing And Control, vol. 17, pp. 55–59, 2015. View at Publisher · View at Google Scholar
  • Alison Callahan, Juan Jose Cifuentes, and Michel Dumontier, “An evidence-based approach to identify aging-related genes in Caenorhabditis elegans,” Bmc Bioinformatics, vol. 16, 2015. View at Publisher · View at Google Scholar
  • Gerwyn Morris, Michael Berk, Ken Walder, and Michael Maes, “Central pathways causing fatigue in neuro-inflammatory and autoimmune illnesses,” BMC Medicine, vol. 13, no. 1, 2015. View at Publisher · View at Google Scholar
  • Christina Tremblay, Joël Macoir, Mélanie Langlois, Léo Cantin, Michel Prud’homme, and Laura Monetta, “The effects of subthalamic deep brain stimulation on metaphor comprehension and language abilities in Parkinson’s disease,” Brain and Language, vol. 141, pp. 103–109, 2015. View at Publisher · View at Google Scholar
  • Li Li, Qiong Yu, and Weimin Liang, “Molecular pathways of mitochondrial dysfunctions: Possible cause of cell death in anesthesia-induced developmental neurotoxicity,” Brain Research Bulletin, vol. 110, pp. 14–19, 2015. View at Publisher · View at Google Scholar
  • Maria P. Bambo, Elena Garcia-Martin, Fernando Gutierrez-Ruiz, Juan Pinilla, Susana Perez-Olivan, Jose M. Larrosa, Vicente Polo, and Luis Pablo, “Analysis of optic disc color changes in Alzheimer's disease: a potential new biomarker,” Clinical Neurology and Neurosurgery, 2015. View at Publisher · View at Google Scholar
  • Ivan Rektor, Martina Bockova, Jan Chrastina, Irena Rektorova, and Marek Balaz, “The modulatory role of subthalamic nucleus in cognitive functions - A viewpoint,” Clinical Neurophysiology, vol. 126, no. 4, pp. 653–658, 2015. View at Publisher · View at Google Scholar
  • Marianne Amalric, “Targeting metabotropic glutamate receptors (mGluRs) in Parkinson's disease,” Current Opinion in Pharmacology, vol. 20, pp. 29–34, 2015. View at Publisher · View at Google Scholar
  • Giulio Lancioni, Nirbhay Singh, Mark O'Reilly, Jeff Sigafoos, Fiora D'Amico, Giovanni Sasanelli, Floriana Denitto, and Russell Lang, “Technology-aided leisure and communication: Opportunities for persons with advanced Parkinson’s disease,” Developmental Neurorehabilitation, pp. 1–7, 2015. View at Publisher · View at Google Scholar
  • Tatjana Gazibara, Tatjana Pekmezovic, Darija Kisic-Tepavcevic, Marina Svetel, Aleksandra Tomic, Iva Stankovic, and Vladimir S. Kostic, “Incidence and prediction of falls in Parkinson's disease: a prospective cohort study,” European Journal Of Epidemiology, vol. 30, no. 4, pp. 349–352, 2015. View at Publisher · View at Google Scholar
  • B. R. Bloem, and F. Stocchi, “Move for Change Part III: a European survey evaluating the impact of the EPDA Charter for People with Parkinson's Disease,” European Journal Of Neurology, vol. 22, no. 1, pp. 133–+, 2015. View at Publisher · View at Google Scholar
  • Ashish Kumar Kakkar, and Neha Dahiya, “Management of Parkinson's disease: Current and future pharmacotherapy,” European Journal Of Pharmacology, vol. 750, pp. 74–81, 2015. View at Publisher · View at Google Scholar
  • Romina Aron Badin, Marta Vadori, Emanuele Cozzi, and Philippe Hantraye, “Translational research for Parkinson׳s disease: The value of pre-clinical primate models,” European Journal of Pharmacology, 2015. View at Publisher · View at Google Scholar
  • Weidong Pan, Mingzhe Wang, Mao Li, Qiudong Wang, Shin Kwak, Wenfei Jiang, and Yoshiharu Yamamoto, “Actigraph Evaluation of Acupuncture for Treating Restless Legs Syndrome,” Evidence-Based Complementary and Alternative Medicine, vol. 2015, pp. 1–7, 2015. View at Publisher · View at Google Scholar
  • Yu-Chi Cheng, Jer-Ming Chang, Chien-An Chen, and Hung-Chun Chen, “Autophagy modulates endoplasmic reticulum stress-induced cell death in podocytes: A protective role,” Experimental Biology And Medicine, vol. 240, no. 4, pp. 467–476, 2015. View at Publisher · View at Google Scholar
  • Hsin-I Hu, Hsin-Hou Chang, and Der-Shan Sun, “Differential regulation of caspase-2 in MPP+-induced apoptosis in primary cortical neurons,” Experimental Cell Research, vol. 332, no. 1, pp. 60–66, 2015. View at Publisher · View at Google Scholar
  • Thomas Müller, “The safety of istradefylline for the treatment of Parkinson’s disease,” Expert Opinion on Drug Safety, pp. 1–7, 2015. View at Publisher · View at Google Scholar
  • Khaled Radad, Rudolf Moldzio, Mubarak Al-Shraim, Barbara Kranner, Christopher Krewenka, and Wolf-Dieter Rausch, “Recent advances in autophagy-based neuroprotection,” Expert Review of Neurotherapeutics, vol. 15, no. 2, pp. 195–205, 2015. View at Publisher · View at Google Scholar
  • Abdul Qayyum Rana, Uzma S Ahmed, Zishan M Chaudry, and Sai Vasan, “Parkinson’s disease: a review of non-motor symptoms,” Expert Review of Neurotherapeutics, vol. 15, no. 5, pp. 549–562, 2015. View at Publisher · View at Google Scholar
  • George E. Barreto, Alexander Iarkov, and Valentina Echeverria Moran, “Beneficial effects of nicotine, cotinine and its metabolites as potential agents for Parkinson’s disease,” Frontiers in Aging Neuroscience, vol. 6, 2015. View at Publisher · View at Google Scholar
  • Alex Tillman, Makii Muthalib, Ashlee M. Hendy, Liam G. Johnson, Timo Rantalainen, Dawson J. Kidgell, Peter G. Enticott, and Wei-Peng Teo, “Lower Limb Progressive Resistance Training Improves Leg Strength but Not Gait Speed or Balance in Parkinson’s Disease: A Systematic Review and Meta-Analysis,” Frontiers in Aging Neuroscience, vol. 7, 2015. View at Publisher · View at Google Scholar
  • Chiara Monti, Heather Bondi, Andrea Urbani, Mauro Fasano, and Tiziana Alberio, “Systems biology analysis of the proteomic alterations induced by MPP+, a Parkinson's disease-related mitochondrial toxin,” Frontiers in Cellular Neuroscience, vol. 9, 2015. View at Publisher · View at Google Scholar
  • Francesco Angelucci, Antonella Peppe, Giovanni A. Carlesimo, Francesca Serafini, Silvia Zabberoni, Francesco Barban, Jacob Shofany, Carlo Caltagirone, and Alberto Costa, “A pilot study on the effect of cognitive training on BDNF serum levels in individuals with Parkinson's disease,” Frontiers In Human Neuroscience, vol. 9, 2015. View at Publisher · View at Google Scholar
  • Francesco Angelucci, Antonella Peppe, Giovanni A. Carlesimo, Francesca Serafini, Silvia Zabberoni, Francesco Barban, Jacob Shofany, Carlo Caltagirone, and Alberto Costa, “A pilot study on the effect of cognitive training on BDNF serum levels in individuals with Parkinson’s disease,” Frontiers in Human Neuroscience, vol. 9, 2015. View at Publisher · View at Google Scholar
  • Maria E. Figueiredo-Pereira, Patricia Rockwell, Thomas Schmidt-Glenewinkel, and Peter Serrano, “Neuroinflammation and J2 prostaglandins: linking impairment of the ubiquitin-proteasome pathway and mitochondria to neurodegeneration,” Frontiers in Molecular Neuroscience, vol. 7, 2015. View at Publisher · View at Google Scholar
  • Maria-Trinidad Herrero, Cristina Estrada, Layal Maatouk, and Sheela Vyas, “Inflammation in Parkinson's disease: role of glucocorticoids,” Frontiers In Neuroanatomy, vol. 9, 2015. View at Publisher · View at Google Scholar
  • María-Trinidad Herrero, Cristina Estrada, Layal Maatouk, and Sheela Vyas, “Inflammation in Parkinson’s disease: role of glucocorticoids,” Frontiers in Neuroanatomy, vol. 9, 2015. View at Publisher · View at Google Scholar
  • Lior Greenbaum, and Bernard Lerer, “Pharmacogenetics of Antipsychotic-Induced Movement Disorders as a Resource for Better Understanding Parkinson’s Disease Modifier Genes,” Frontiers in Neurology, vol. 6, 2015. View at Publisher · View at Google Scholar
  • Malav S. Trivedi, and Richard Deth, “Redox-based epigenetic status in drug addiction: a potential contributor to gene priming and a mechanistic rationale for metabolic intervention,” Frontiers in Neuroscience, vol. 8, 2015. View at Publisher · View at Google Scholar
  • Sergio A. Salamanca, Edra E. Sorrentino, Joshua D. Nosanchuk, and Luis R. Martinez, “Impact of methamphetamine on infection and immunity,” Frontiers in Neuroscience, vol. 8, 2015. View at Publisher · View at Google Scholar
  • Jinzi Wu, Xiaoting Luo, and Liang-Jun Yan, “Two dimensional blue native/SDS-PAGE to identify mitochondrial complex I subunits modified by 4-hydroxynonenal (HNE),” Frontiers in Physiology, vol. 6, 2015. View at Publisher · View at Google Scholar
  • Xin Du, and Terence Y. Pang, “Is Dysregulation of the HPA-Axis a Core Pathophysiology Mediating Co-Morbid Depression in Neurodegenerative Diseases?,” Frontiers in Psychiatry, vol. 6, 2015. View at Publisher · View at Google Scholar
  • Vincenzo Calvo, Francesca Bianco, Enrico Benelli, Marco Sambin, Maria R. Monsurrò, Cinzia Femiano, Giorgia Querin, Gianni Sorarù, and Arianna Palmieri, “Impact on children of a parent with ALS: a case-control study,” Frontiers in Psychology, vol. 6, 2015. View at Publisher · View at Google Scholar
  • Shinichi Amano, Deborah Kegelmeyer, and S. Lee Hong, “Rethinking energy in parkinsonian motor symptoms: a potential role for neural metabolic deficits,” Frontiers in Systems Neuroscience, vol. 8, 2015. View at Publisher · View at Google Scholar
  • Alberto Costa, and Carlo Caltagirone, “Individual differences in approach-avoidance aptitude: some clues from research on Parkinson’s disease,” Frontiers in Systems Neuroscience, vol. 9, 2015. View at Publisher · View at Google Scholar
  • P. C. Poortvliet, P. A. Silburn, T. J. Coyne, and H. J. Chenery, “Deep brain stimulation for Parkinson disease in Australia: current scientific and clinical status,” Internal Medicine Journal, vol. 45, no. 2, pp. 134–139, 2015. View at Publisher · View at Google Scholar
  • Maria Haak, Bjorn Slaug, Frank Oswald, Steven M. Schmidt, Joseph M. Rimland, Signe Tomsone, Thomas Lado, Torbjorn Svensson, and Susanne Iwarsson, “Cross-National User Priorities for Housing Provision and Accessibility - Findings from the European innovAge Project,” International Journal Of Environmental Research And Public Health, vol. 12, no. 3, pp. 2670–2686, 2015. View at Publisher · View at Google Scholar
  • Akari Minami, Atsuko Nakanishi, Satoru Matsuda, Yasuko Kitagishi, and Yasunori Ogura, “Function of alpha-synuclein and PINK1 in Lewy body dementia,” International Journal Of Molecular Medicine, vol. 35, no. 1, pp. 3–9, 2015. View at Publisher · View at Google Scholar
  • Speranza Rubattu, Beniamino Pagliaro, Giorgia Pierelli, Caterina Santolamazza, Sara Di Castro, Silvia Mennuni, and Massimo Volpe, “Pathogenesis of Target Organ Damage in Hypertension: Role of Mitochondrial Oxidative Stress,” International Journal Of Molecular Sciences, vol. 16, no. 1, pp. 823–839, 2015. View at Publisher · View at Google Scholar
  • Sara Marceglia, Elena Rossi, Manuela Rosa, Filippo Cogiamanian, Lorenzo Rossi, Laura Bertolasi, Alberto Vogrig, Francesco Pinciroli, Sergio Barbieri, and Alberto Priori, “Web-Based Telemonitoring and Delivery of Caregiver Support for Patients With Parkinson Disease After Deep Brain Stimulation: Protocol,” JMIR Research Protocols, vol. 4, no. 1, pp. e30, 2015. View at Publisher · View at Google Scholar
  • John W. Wright, and Joseph W. Harding, “The Brain Hepatocyte Growth Factor/c-Met Receptor System: A New Target for the Treatment of Alzheimer's Disease,” Journal Of Alzheimers Disease, vol. 45, no. 4, pp. 985–1000, 2015. View at Publisher · View at Google Scholar
  • Robert P. Friedland, “Mechanisms of Molecular Mimicry Involving the Microbiota in Neurodegeneration,” Journal Of Alzheimers Disease, vol. 45, no. 2, pp. 349–362, 2015. View at Publisher · View at Google Scholar
  • Sandra A. Acosta, Naoki Tajiri, Ike de la Pena, Marina Bastawrous, Paul R. Sanberg, Yuji Kaneko, and Cesar V. Borlongan, “Alpha-Synuclein as a Pathological Link Between Chronic Traumatic Brain Injury and Parkinson's Disease,” Journal Of Cellular Physiology, vol. 230, no. 5, pp. 1024–1032, 2015. View at Publisher · View at Google Scholar
  • Giuseppe Frazzitta, Roberto Maestri, Davide Ferrazzoli, Giulio Riboldazzi, Rossana Bera, Cecilia Fontanesi, Roger P Rossi, Gianni Pezzoli, and Maria F Ghilardi, “Multidisciplinary intensive rehabilitation treatment improves sleep quality in Parkinson’s disease,” Journal of Clinical Movement Disorders, vol. 2, no. 1, 2015. View at Publisher · View at Google Scholar
  • Xiaoyan Guo, Wei Song, Ke Chen, XuePing Chen, Zhenzhen Zheng, Bei Cao, Rui Huang, Bi Zhao, Ying Wu, and Hui-Fang Shang, “Associations between neuropsychiatric symptoms and cognition in Chinese idiopathic Parkinson's disease patients,” Journal Of Clinical Neuroscience, vol. 22, no. 3, pp. 578–582, 2015. View at Publisher · View at Google Scholar
  • Matlou I. Mokgobu, Moloko C. Cholo, Ronald Anderson, Helen C. Steel, Maraki P. Motheo, Thembani N. Hlatshwayo, Gregory R. Tintinger, and Annette J. Theron, “Oxidative induction of pro-inflammatory cytokine formation by human monocyte-derived macrophages following exposure to manganese in vitro,” Journal Of Immunotoxicology, vol. 12, no. 1, pp. 98–103, 2015. View at Publisher · View at Google Scholar
  • Kyoung Hoon Jeong, Min-Tae Jeon, Heung Deok Kim, Un Ju Jung, Min Cheol Jang, Jin Woo Chu, Seung Jun Yang, Il Yoon Choi, Myung-Sook Choi, and Sang Ryong Kim, “Nobiletin Protects Dopaminergic Neurons in the 1-Methyl-4-Phenylpyridinium-Treated Rat Model of Parkinson's Disease,” Journal Of Medicinal Food, vol. 18, no. 4, pp. 409–414, 2015. View at Publisher · View at Google Scholar
  • Debapriya Garabadu, B. C. M. Harshavardhan Reddy, and Sairam Krishnamurthy, “Citalopram Protects Against Cold-Restraint Stress-Induced Activation of Brain-Derived Neurotrophic Factor and Expression of Nuclear Factor Kappa-Light,” Journal Of Molecular Neuroscience, vol. 55, no. 2, pp. 355–366, 2015. View at Publisher · View at Google Scholar
  • Michael J. Hurley, Steve M. Gentleman, and David T. Dexter, “Calcium Ca(V)1 Channel Subtype mRNA Expression in Parkinson's Disease Examined by In Situ Hybridization,” Journal Of Molecular Neuroscience, vol. 55, no. 3, pp. 715–724, 2015. View at Publisher · View at Google Scholar
  • Sheila de Melo Borges, Márcia Radanovic, and Orestes Vicente Forlenza, “Functional Mobility in a Divided Attention Task in Older Adults With Cognitive Impairment,” Journal of Motor Behavior, pp. 1–8, 2015. View at Publisher · View at Google Scholar
  • Olie Westheimer, Cynthia McRae, Claire Henchcliffe, Arman Fesharaki, Sofya Glazman, Heather Ene, and Ivan Bodis-Wollner, “Dance for PD: a preliminary investigation of effects on motor function and quality of life among persons with Parkinson’s disease (PD),” Journal of Neural Transmission, 2015. View at Publisher · View at Google Scholar
  • José Christian Machado Ximenes, Kelly Rose Tavares Neves, Luzia Kalyne A. M. Leal, Marta Regina Santos do Carmo, Gerly Anne de Castro Brito, Maria da Graça Naffah-Mazzacoratti, Ésper Abrão Cavalheiro, and Glauce Socorro de Barros Viana, “Valproic Acid Neuroprotection in the 6-OHDA Model of Parkinson’s Disease Is Possibly Related to Its Anti-Inflammatory and HDAC Inhibitory Properties,” Journal of Neurodegenerative Diseases, vol. 2015, pp. 1–14, 2015. View at Publisher · View at Google Scholar
  • Jane Kovalevich, William Yen, Ahmet Ozdemir, and Dianne Langford, “Cocaine Induces Nuclear Export and Degradation of Neuronal Retinoid X Receptor-gamma via a TNF-alpha/JNK- Mediated Mechanism,” Journal Of Neuroimmune Pharmacology, vol. 10, no. 1, pp. 55–73, 2015. View at Publisher · View at Google Scholar
  • Shou-Peng Fu, Jian-Fa Wang, Wen-Jing Xue, Hong-Mei Liu, Bing-run Liu, Ya-Long Zeng, Su-Nan Li, Bing-Xu Huang, Qing-Kang Lv, Wei Wang, and Ju-Xiong Liu, “Anti-inflammatory effects of BHBA in both in vivo and in vitro Parkinson's disease models are mediated by GPR109A-dependent mechanisms,” Journal Of Neuroinflammation, vol. 12, 2015. View at Publisher · View at Google Scholar
  • Allon Goldberg, Catherine L. Curtis, and Jeffrey A. Kleim, “Linking Genes to Neurological Clinical Practice: The Genomic Basis for Neurorehabilitation,” Journal Of Neurologic Physical Therapy, vol. 39, no. 1, pp. 52–61, 2015. View at Publisher · View at Google Scholar
  • Jennifer L. Wilhelm, and Laurie A. King, “Exercise for Persons with Parkinson Disease: Important Considerations of Medication, Assessment, and Training,” Journal Of Neurologic Physical Therapy, vol. 39, no. 2, pp. 93–94, 2015. View at Publisher · View at Google Scholar
  • Matt J. N. Brown, Quincy J. Almeida, and Fariborz Rahimi, “The dopaminergic system in upper limb motor blocks (ULMB) investigated during bimanual coordination in Parkinson's disease (PD),” Journal Of Neurology, vol. 262, no. 1, pp. 41–53, 2015. View at Publisher · View at Google Scholar
  • Carsten Eggers, Miriam Guenther, John Rothwell, Lars Timmermann, and Diane Ruge, “Theta burst stimulation over the supplementary motor area in Parkinson's disease,” Journal Of Neurology, vol. 262, no. 2, pp. 357–364, 2015. View at Publisher · View at Google Scholar
  • Yasuhiro Tanaka, Takashi Tsuboi, Hirohisa Watanabe, Yasukazu Kajita, Yasushi Fujimoto, Reiko Ohdake, Noritaka Yoneyama, Michihito Masuda, Kazuhiro Hara, Joe Senda, Mizuki Ito, Naoki Atsuta, Satoshi Horiguchi, Masahiko Yamamoto, Toshihiko Wakabayashi, and Gen Sobue, “Voice features of Parkinson’s disease patients with subthalamic nucleus deep brain stimulation,” Journal of Neurology, 2015. View at Publisher · View at Google Scholar
  • N. G. Margraf, A. Rohr, O. Granert, J. Hampel, A. Drews, and G. Deuschl, “MRI of lumbar trunk muscles in patients with Parkinson’s disease and camptocormia,” Journal of Neurology, 2015. View at Publisher · View at Google Scholar
  • Marijean Buhse, Carol Della Ratta, Janet Galiczewski, and Patricia Eckardt, “Caregivers of Older Persons With Multiple Sclerosis: Determinants of Health-Related Quality of Life,” Journal Of Neuroscience Nursing, vol. 47, no. 2, pp. E2–E12, 2015. View at Publisher · View at Google Scholar
  • Daniel R. Seichepine, Sandy Neargarder, Sigurros Davidsdottir, Gretchen O. Reynolds, and Alice Cronin-Golomb, “Side and Type of Initial Motor Symptom Influences Visuospatial Functioning in Parkinson's Disease,” Journal Of Parkinsons Disease, vol. 5, no. 1, pp. 75–83, 2015. View at Publisher · View at Google Scholar
  • Guillaume Lamotte, Miriam R. Rafferty, Janey Prodoehl, Wendy M. Kohrt, Cynthia L. Comella, Tanya Simuni, and Daniel M. Corcos, “Effects of Endurance Exercise Training on The Motor and Non-Motor Features of Parkinson's Disease: A Review,” Journal Of Parkinsons Disease, vol. 5, no. 1, pp. 21–41, 2015. View at Publisher · View at Google Scholar
  • Richard G. Brown, and Bruce A. Fernie, “Metacognitions, anxiety, and distress related to motor fluctuations in Parkinson's disease,” Journal Of Psychosomatic Research, vol. 78, no. 2, pp. 143–148, 2015. View at Publisher · View at Google Scholar
  • Jason C. Dorman, Verle D. Valentine, Thayne A. Munce, B. Joel Tjarks, Paul A. Thompson, and Michael F. Bergeron, “Tracking postural stability of young concussion patients using dual-task interference,” Journal Of Science And Medicine In Sport, vol. 18, no. 1, pp. 2–7, 2015. View at Publisher · View at Google Scholar
  • Charles H. Brown, Candice Morrissey, Masahiro Ono, Gayane Yenokyan, Ola A. Selnes, Jeremy Walston, Laura Max, Andrew LaFlam, Karin Neufeld, Rebecca F. Gottesman, and Charles W. Hogue, “Impaired Olfaction and Risk of Delirium or Cognitive Decline After Cardiac Surgery,” Journal of the American Geriatrics Society, vol. 63, no. 1, pp. 16–23, 2015. View at Publisher · View at Google Scholar
  • Andrea M. Loftus, Romola S. Bucks, Meghan Thomas, Robert Kane, Caitlin Timms, Roger A. Barker, and Natalie Gasson, “Retrospective Assessment of Movement Disorder Society Criteria for Mild Cognitive Impairment in Parkinson's Disease,” Journal Of The International Neuropsychological Society, vol. 21, no. 2, pp. 137–145, 2015. View at Publisher · View at Google Scholar
  • Anders Uhrbrand, Egon Stenager, Martin Sloth Pedersen, and Ulrik Dalgas, “Parkinson's Disease and Intensive Exercise Therapy - a Systematic Review and Meta-analysis of Randomized Controlled Trials,” Journal of the Neurological Sciences, 2015. View at Publisher · View at Google Scholar
  • Jessica Chorostecki, Navid Seraji-Bozorgzad, Aashka Shah, Fen Bao, Ginny Bao, Edwin George, Veronica Gorden, Christina Caon, Elliot Frohman, M. Tariq Bhatti, and Omar Khan, “Characterization of Retinal Architecture in Parkinson’s Disease,” Journal of the Neurological Sciences, 2015. View at Publisher · View at Google Scholar
  • Roberto E. Sica, “Could astrocytes be the primary target of an offending agent causing the primary degenerative diseases of the human central nervous system? A hypothesis,” Medical Hypotheses, 2015. View at Publisher · View at Google Scholar
  • Travis M. Cruickshank, Alvaro R. Reyes, and Melanie R. Ziman, “A Systematic Review and Meta-Analysis of Strength Training in Individuals With Multiple Sclerosis Or Parkinson Disease,” Medicine, vol. 94, no. 4, pp. e411, 2015. View at Publisher · View at Google Scholar
  • H. Zhang, C. Duan, and H. Yang, “Defective Autophagy in Parkinson's Disease: Lessons from Genetics,” Molecular Neurobiology, vol. 51, no. 1, pp. 89–104, 2015. View at Publisher · View at Google Scholar
  • Roberto Erro, Marina Picillo, Marianna Amboni, Marcello Moccia, Carmine Vitale, Katia Longo, Maria Teresa Pellecchia, Gabriella Santangelo, Pablo Martinez-Martin, K. Ray Chaudhuri, and Paolo Barone, “Nonmotor Predictors for Levodopa Requirement in De Novo Patients With Parkinson's Disease,” Movement Disorders, vol. 30, no. 3, pp. 373–378, 2015. View at Publisher · View at Google Scholar
  • Xiao Hu, Xiaopeng Song, Yonggui Yuan, Erfeng Li, Jiajia Liu, Weiguo Liu, and Yijun Liu, “Abnormal Functional Connectivity of the Amygdala Is Associated With Depression in Parkinson's Disease,” Movement Disorders, vol. 30, no. 2, pp. 238–244, 2015. View at Publisher · View at Google Scholar
  • Doris E. Payer, Mark Guttman, Stephen J. Kish, Junchao Tong, Antonio Strafella, Martin Zack, John R. Adams, Pablo Rusjan, Sylvain Houle, Yoshiaki Furukawa, Alan A. Wilson, and Isabelle Boileau, “[C-11]-(+)-PHNO PET Imaging of Dopamine D-2/3 Receptors in Parkinson's Disease With Impulse Control Disorders,” Movement Disorders, vol. 30, no. 2, pp. 160–166, 2015. View at Publisher · View at Google Scholar
  • Nadeeka N.W. Dissanayaka, Elizabeth White, John D. O'Sullivan, Rodney Marsh, Peter A. Silburn, David A. Copland, George D. Mellick, and Gerard J. Byrne, “Characteristics and Treatment of Anxiety Disorders in Parkinson's Disease,” Movement Disorders Clinical Practice, 2015. View at Publisher · View at Google Scholar
  • Atsushi Tsujimura, Katsutoshi Taguchi, Yoshihisa Watanabe, Harutsugu Tatebe, Takahiko Tokuda, Toshiki Mizuno, and Masaki Tanaka, “Lysosomal enzyme cathepsin B enhances the aggregate forming activity of exogenous alpha-synuclein fibrils,” Neurobiology Of Disease, vol. 73, pp. 244–253, 2015. View at Publisher · View at Google Scholar
  • Mariza Bortolanza, Roberta Cavalcanti-Kiwiatkoski, Fernando E. Padovan-Neto, Celia Aparecida da-Silva, Miso Mitkovski, Rita Raisman-Vozari, and Elaine Del-Bel, “Glial activation is associated with L-DOPA induced dysldnesia and blocked by a nitric oxide synthase inhibitor in a rat model of Parkinson's disease,” Neurobiology Of Disease, vol. 73, pp. 377–387, 2015. View at Publisher · View at Google Scholar